Therefore, we select the CONUT score to evaluate the malnutrition of patients with r/r AML and predicted CRS/ICANS of r/r AML patients treated with CLL1 CAR-T by dynamic changes of CONUT. This evidence concerns the gene CLEC12A and acute myeloid leukemia.